Informationen:
Fehler:
ID
16590
Beschreibung
Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00193544
Link
https://clinicaltrials.gov/show/NCT00193544
Stichworte
Versionen (1)
- 25.07.16 25.07.16 -
Hochgeladen am
25. Juli 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Multiple Myeloma NCT00193544
Eligibility Multiple Myeloma NCT00193544
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Multiple Myeloma NCT00193544
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
inclusion criteria
Item
to be included in this study, you must meet the following criteria:
boolean
multiple myeloma
Item
confirmed diagnosis of multiple myeloma
boolean
C0026764 (UMLS CUI [1])
prior chemotherapy
Item
received at least one previous chemotherapy regimen at most 3 previous
boolean
C1514457 (UMLS CUI [1])
thalidomide chemotherapy
Item
thalidomide with or without dexamethasone without chemotherapy will not factor in to total number of regimens.
boolean
C0392920 (UMLS CUI [1,1])
C0039736 (UMLS CUI [1,2])
C0039736 (UMLS CUI [1,2])
age
Item
age at least 18 years years
boolean
C0001779 (UMLS CUI [1])
living with minimal assistance
Item
able to perform activities of daily living with minimal assistance
boolean
C0021189 (UMLS CUI [1])
life expectancy
Item
life expectancy more than 3 months
boolean
C0023671 (UMLS CUI [1])
comorbidity
Item
adequate bone marrow, liver and kidney function
boolean
C0009488 (UMLS CUI [1])
written informed consent
Item
must give written informed consent in order to participate.
boolean
C0021430 (UMLS CUI [1])
exclusion criteria
Item
you cannot participate in this study if any of the following apply to you:
boolean
pregnant or lactating
Item
women pregnant or lactating.
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])
pre-existing moderate neuropathy
Item
pre-existing moderate neuropathy
boolean
C0442874 (UMLS CUI [1])
significant cardiac dysfunction
Item
patients with significant underlying cardiac dysfunction
boolean
C3277906 (UMLS CUI [1])
uncontrolled hypercalcemia
Item
uncontrolled hypercalcemia
boolean
C0020437 (UMLS CUI [1])
untreated communicable disease
Item
active serious infections not controlled by antibiotics
boolean
C0009450 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0332155 (UMLS CUI [1,2])
history of grand mal seizures
Item
history of grand mal seizures (other than infantile febrile seizures)
boolean
C0014544 (UMLS CUI [1])
medications that prolong the qt interval.
Item
receiving other medications that prolong the qt interval.
boolean
C0429028 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
ID.18
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean